Clinical Trial Update: Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer [Phase 1, Phase 2]

View source ↗

Summary

Early-phase trial update on a CEA-targeted CAR-T therapy for relapsed/refractory CEA-positive solid tumors, including lung and colorectal cancers, with Phase 1 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Liver Cancer
• Lung Cancer
• Pancreatic Cancer
• Solid Tumors

Drugs mentioned

• CEA-targeted CAR-T therapy (CAR-T cell therapy targeting carcinoembryonic antigen (CEA))

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Solid Tumor, Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN